"The patent is for the “Transplantation of human neural cells for treatment of neurodegenerative conditions.” Could this be the next step in developing its NSI-566 treatment? Why I say this is because the treatment is specifically designed around neural stem cells. This is developing as things just began to unfold later in the afternoon. However, it could become one of the penny stocks to watch this month."
You post technical's but don't know whats going on as far as news ? Seneca Biopharma Inc. (SNCA) shares recently traded up 151% to $3.14 Friday after the company noted "meetings with potential joint venture and strategic partners" in a Thursday securities filing.
berg123
⋅
What are your thoughts now given today's price crashing move of issuing discounted warrants at 2pm when stock was soaring much much higher? TIA